Exchange Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.33M Sell
1,702
-105
-6% -$81.6K 0.2% 111
2025
Q1
$1.49M Sell
1,807
-144
-7% -$120K 0.24% 102
2024
Q4
$1.51M Sell
1,951
-7
-0.4% -$5.8K 0.24% 100
2024
Q3
$1.73M Sell
1,958
-2
-0.1% -$1.8K 0.28% 100
2024
Q2
$1.77M Sell
1,960
-35
-2% -$28K 0.29% 98
2024
Q1
$1.55M Buy
1,995
+320
+19% +$228K 0.25% 100
2023
Q4
$976K Buy
1,675
+482
+40% +$281K 0.18% 118
2023
Q3
$641K Hold
1,193
0.12% 135
2023
Q2
$559K Buy
1,193
+92
+8% +$38.6K 0.1% 136
2023
Q1
$378K Buy
+1,101
New +$371K 0.08% 145
2018
Q4
Sell
-100
Closed -$11K 208
2018
Q3
$11K Buy
+100
New +$10K ﹤0.01% 236
2017
Q1
Sell
-370
Closed -$27K 224
2016
Q4
$27K Hold
370
0.01% 117
2016
Q3
$30K Hold
370
0.01% 126
2016
Q2
$29K Buy
+370
New +$27.9K 0.01% 123
2015
Q1
Sell
-589
Closed -$41K 228
2014
Q4
$41K Buy
589
+69
+13% +$4.66K 0.02% 112
2014
Q3
$34K Buy
520
+1
+0.2% +$63 0.01% 108
2014
Q2
$32K Buy
519
+1
+0.2% +$60 0.01% 106
2014
Q1
$30K Buy
518
+168
+48% +$9.38K 0.01% 117
2013
Q4
$18K Buy
350
+259
+285% +$13K 0.01% 121
2013
Q3
$5K Buy
91
+25
+38% +$1.31K ﹤0.01% 165
2013
Q2
$3K Buy
+66
New +$3.59K ﹤0.01% 166

Other funds holding LLY

Exchange Capital Management's LLY Position: Q2 2025 in Review

Exchange Capital Management reduced its Eli Lilly (LLY) stake by 5.8% in Q2 2025, selling an estimated $81.6K and leaving 1,702 shares worth $1.33M. The position accounts for 0.2% of the portfolio, ranked #111.

Exchange Capital Management first reported a position in LLY in Q2 2013 and has held it in 21 quarters since. The position peaked at $1.77M in Q2 2024. 3,914 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • Exchange Capital Management held 1,702 shares of Eli Lilly worth $1.33M as of Q2 2025.
  • Exchange Capital Management sold 105 Eli Lilly shares in Q2 2025, an estimated $81.6K.
  • Eli Lilly made up 0.2% of Exchange Capital Management's portfolio in Q2 2025, its #111 holding.
  • Exchange Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 21 quarters since.
  • Exchange Capital Management's Eli Lilly position peaked at $1.77M in Q2 2024.
  • 3,914 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Exchange Capital Management's 13F filing for Q2 2025, filed 21 Jul 2025.